serine proteases of physiological importance. Their tissue specific functions are largely unknown, but they are known to produce the inflammatory mediator kallidin (lysyl-bradykinin).t Kallidin belongs to the group of vasoactive peptides known as kinins. Many of the effects of kinins, including vasodilatation, increased vascular permeability, leucotaxis, and pain, occur in inflammatory joint disease.2 When bradykinin was injected into the knees of dogs it produced acute heat, pain, and effusion.3 Furthermore, both bradykinin4 and kallidin5 have recently been put forward as possible mediators of bone resorption. In 1957 Armstrong et al first described a pain producing substance similar to bradykinin in the synovial fluid of patients with rheumatoid arthritis (RA). 6 Although bradykinin had been reported in fluid from inflamed3 and gouty7 joints, it was only later shown to be present in greater amounts than in osteoarthritic (OA) joints.
Plasma kallikrein, the serine protease that forms bradykinin, is a component of the intrinsic blood coagulation cascade and was first implicated in gout by Kellermeyer and Breckenridge.9 Subsequently, plasma kallikrein was detected in RA synovial fluid by Jasani et al,'0 and it has recently been shown that significantly higher activity is present in RA than in OA synovial fluid.'1 Unlike plasma kallikrein, tissue kallikrein has hitherto not been positively identified in joint fluid. The two enzymes differ in structure, physicochemical and immunological properties, and in their susceptibility to inhibitors. 12 cleavage of the substrate produces p-nitroaniline (pNA). 16 The reaction was carried out at 37°C and pH 8-2 in the presence of soybean trypsin inhibitor (cuvette concentration 125 tig/ml). The rate of increase in absorption at 405 nm was followed on a Unicam SP1800 spectrophotometer. The activity of amidase resistant to soybean trypsin inhibitor was expressed as tissue kallikrein equivalents in mU/ml, where one unit (U) of tissue kallikrein hydrolyses 1 .tmol/itre substrate per minute. To measure the proenzyme amidase activity the sample was activated with bovine trypsin (100 ig/ml) for 15 minutes at 37°C. The reaction was stopped with soybean trypsin inhibitor (100 ig/ml) and the tissue kallikrein equivalent activity measured as before. 17 Activity of the proenzyme (inactive) was determined by subtracting the value for active from that obtained after trypsinisation. The concentration of soybean trypsin inhibitor (125 ,ug/ml) in the reaction mixture was sufficient to inhibit the activity of plasma kallikrein ILg/ml) and elastase (3.75 ig/ml) on the H-D-Val-Leu-Arg-pNA substrate. The amidases resistant to soybean trypsin inhibitor (active and proenzyme) were almost completely (90%-95%) inhibited by aprotinin (5000 kIU/ml).
, was added to inhibit the bovine trypsin as well as the plasma kallikrein; the incubation was continued for 10 minutes at 37°C and a further 10 minutes at room temperature to permit degradation of kinin by kininases known to be present in synovial fluid. This reaction mixture was subsequently assayed for free kinin and for kininogenase activity and its inhibition by aprotinin, according to the methods described by
To measure free kinin the final incubate was mixed with absolute ethanol (1 ml) and heated for 10 minutes to 70°C. After centrifugation the supernatant was removed quantitatively, evaporated, and the dried residue analysed for kinin.
To measure the kininogenase activity and its inhibition by aprotinin two aliquots (50 RI) of the final incubate were mixed, one with 100 mM NaH2PO4, 3 mM 1,10-phenanthroline, 30 mM edetic acid pH 8-5 and the other, in addition, with aprotinin solution (5 tsg/ml in the same buffer).
After 10 minutes at room temperature (to allow complex formation with aprotinin) kininogenase activity was determined as described by Fink et al.21
In brief: the sample (50 ,ul) was incubated with dog kininogen at 37°C for 30 minutes in the presence of kininase inhibitors; next, ethanol was added to stop the reaction and precipitate proteins. After centrifugation the supernatant (which contained the released kinin) was evaporated to dryness. 
